Answers are grounded in this paper and cite their sources.
Background Age-related skin elasticity loss is expressed through slower recoil after deformation, reduced firmness, and increasing dermal laxity. These phenotypes reflect the condition of a long-lived dermal elastic system embedded within a mechanically integrated extracellular matrix. Objective This five-chapter review develops the Keyora Age-Related Elastic Recoil Response Matrix, connecting intrinsic dermal aging, elastic-fiber network integrity, objective biomechanical measurement, preparation-specific human oral elastin-peptide interventions, and practical nutritional interpretation. Scientific Integration Chapter 1 establishes the intrinsic-aging foundation. Human histology by Braverman and Fonferko (1982) identified age-associated elastic-fiber abnormalities in sun-protected buttock skin: disintegration-like changes affected a minority of fibers at ages 30–70 and a majority after age 70. The Keyora Intrinsic Elastic Aging Map integrates mature elastin persistence, fibroblast homeostasis, tropoelastin production, fibrillin-dependent organization, and extracellular matrix maintenance. Chapter 2 examines elastic-fiber continuity, branching, depth-dependent architecture, fibrillin-rich microfibrils, and mature elastin cross-linking. Oxytalan, elaunin, and elastin-rich fibers form an organized dermal system, while desmosine and isodesmosine characterize mature elastin cross-links. The Keyora Elastic Network Integrity Matrix connects network organization with mechanical load distribution and dermal recovery. Chapter 3 defines skin extensibility, immediate retraction, total recovery, and dermal laxity as related but distinct phenotypes. Cutometer measurement links negative-pressure deformation (Ue, Uv, Uf) with post-release recovery (Ur, Ua). R2 = Ua/Uf, R5 = Ur/Ue, and R7 = Ur/Uf provide complementary elasticity endpoints. Langton et al. (2017) reported photoprotected buttock-skin values of R2 0.92 in both participant groups, R5 0.86 and 0.83, and R7 0.67 and 0.63. Abbas et al. (2022) examined parameter reproducibility in 20 adults across repeated Cutometer trials. Chapter 4 integrates preparation-specific human intervention evidence. Sato et al. (2011) studied 39 middle-aged volunteers receiving porcine aorta-derived elastin peptide at 0, 100, or 200 mg/day for eight weeks; both active groups showed significant within-group elasticity increases, and the 200 mg group improved significantly more than control. Shiratsuchi et al. (2016) reported approximately 4% elasticity improvement with fish-derived elastin hydrolysate versus 2% with placebo, alongside complementary fibroblast findings. Seong et al. (2024) investigated bonito-derived peptide at 100 mg/day for 12 weeks in 100 participants, measuring wrinkle, hydration, and pigmentation outcomes. Conclusion Chapter 5 integrates these evidence streams through the Keyora Preparation-to-Elasticity Match Algorithm—IDENTIFY, QUANTIFY, MATCH, and DECIDE - and the Keyora Human Elasticity Clinical Evidence Registry. Keyora’s label specifies 20 mg of tilapia-derived elastin peptides per two-tablet serving. This defined product identity is positioned within a preparation-aware framework that preserves distinctions among source species, peptide preparation, dose, duration, population, and endpoint. The resulting Keyora Age-Related Elastic Recoil Response Matrix links human dermal structure, quantitative recoil measurement, and positive preparation-specific intervention findings to guide evidence-informed evaluation of skin resilience and elastin-peptide nutrition.
No takes yet. Share an insight, caveat, or question.
Xu Jin (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: